Cranberry Capsules 35,000mg High Strength - with Probiotics/Bio Cultures and Vitamin C - 150 Capsules - Advanced Cranberry Extract Supplement - Made in UK by VitaBright

Product Information

Foda M, Middlebrook PF, Gatfield CT, and et al. Efficacy of cranberry in prevention of urinary tract infection in a susceptible pediatric population. Canadian J Urology 1995;2(1):98-102.

Probiotic Supplements | Renew Life Official Site Probiotic Supplements | Renew Life Official Site

Ohnishi, R., Ito, H., Kasajima, N., Kaneda, M., Kariyama, R., Kumon, H., Hatano, T., and Yoshida, T. Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci.Biotechnol.Biochem 2006;70(7):1681-1687. View abstract. The substantial reduction in both the number of UTIs and antibiotic courses achieved in this trial is extremely encouraging."​ Results Pedersen CB, Kyle J, Jenkinson AM, et al. Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy female volunteers. Eur J Clin Nutr 2000;54:405-8. View abstract.Nahata, M. C., Cummins, B. A., McLeod, D. C., Schondelmeyer, S. W., and Butler, R. Effect of urinary acidifiers on formaldehyde concentration and efficacy with methenamine therapy. Eur.J Clin Pharmacol. 1982;22(3):281-284. View abstract. Individual studies have an inherent risk of publication bias, which is defined as the tendency for authors of research to publish significant results. In other words, a study with a high association between the likelihood of a publication and the statistical significance of a study result is said to have a high publication bias [ 33]. Due to the small amount of included studies, an analysis of publication bias would likely be too underpowered to provide an accurate estimation [ 33]. Therefore, a funnel plot was not included in our meta analysis. Related topics Research Supplements Proteins, peptides, amino acids Women's health Related products show Hormoznejad R, Mohammad Shahi M, Rahim F, Helli B, Alavinejad P, Sharhani A. Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial. Int J Food Sci Nutr. 2020:1-10. View abstract. Howell, A. B. and Foxman, B. Cranberry juice and adhesion of antibiotic-resistant uropathogens. JAMA 6-19-2002;287(23):3082-3083. View abstract.

vH essentials Probiotics with Prebiotics and Cranberry vH essentials Probiotics with Prebiotics and Cranberry

Babar A, Moore L, Leblanc V, et al. High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a double-blind randomized controlled trial. BMC Urol 2021;21(1):44. View abstract. Ferrara, P., Romaniello, L., Vitelli, O., Gatto, A., Serva, M., and Cataldi, L. Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scand.J Urol.Nephrol. 2009;43(5):369-372. View abstract. Kinney AB, Blount M. Effect of cranberry juice on urinary pH. Nurs Res 1979;28:287-90. View abstract. Foxman, B., Geiger, A. M., Palin, K., Gillespie, B., and Koopman, J. S. First-time urinary tract infection and sexual behavior. Epidemiology 1995;6(2):162-168. View abstract.Reid, G., Hsiehl, J., Potter, P., Mighton, J., Lam, D., Warren, D., and Stephenson, J. Cranberry juice consumption may reduce biofilms on uroepithelial cells: pilot study in spinal cord injured patients. Spinal Cord. 2001;39(1):26-30. View abstract. Nahata, M. C., Cummins, B. A., McLeod, D. C., and Butler, R. Predictability of methenamine efficacy based on type of urinary pathogen and pH. J Am.Geriatr.Soc. 1981;29(5):236-239. View abstract. Heterogeneity was analyzed using a chi-squared test on N-1 degrees of freedom. An alpha value of 0.05 was used for statistical significance with the I 2 test [ 32]. I 2 values of 25%, 50% and 75% correspond to low, medium and high levels of heterogeneity, respectively. The rate of UTI recurrence was 21.3% (30/141) in the treatment group and 32.2% (46/143) in the control group. Our analysis of the data showed that probiotics did not have a statistically significant effect in reducing the rate of UTI recurrence (Risk Ratio (RR): 0.59 confidence interval (CI): 0.26, 1.33), Heterogeneity: Chi² = 6.63, df = 2 (p = 0.04); I² =70%, Test for overall effect: Z = 1.27 (p = 0.20) (Figure ​ (Figure2). 2). Although the forest plot demonstrated a trend towards benefit in the treatment arms, there was no statistically significant difference in the combined analysis. This finding will be further discussed in the discussion section.